Cargando…

Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea

BACKGROUND: In Melanesia, the prevalence of trachomatous inflammation–follicular (TF) suggests that public health–level interventions against active trachoma are needed. However, the prevalence of trachomatous trichiasis is below the threshold for elimination as a public health problem and evidence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macleod, Colin K, Butcher, Robert, Javati, Sarah, Gwyn, Sarah, Jonduo, Marinjho, Abdad, Mohammad Yazid, Roberts, Chrissy H, Keys, Drew, Koim, Samuel Peter, Ko, Robert, Garap, Jambi, Pahau, David, Houinei, Wendy, Martin, Diana L, Pomat, William S, Solomon, Anthony W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850549/ https://www.ncbi.nlm.nih.gov/pubmed/31965155 http://dx.doi.org/10.1093/cid/ciaa042

Ejemplares similares

Population-Based Trachoma Mapping in Six Evaluation Units of Papua New Guinea
por: Ko, Robert, et al.
Publicado: (2016)

Diversity of Leptospira spp. in bats and rodents from Papua New Guinea
por: Javati, Sarah, et al.
Publicado: (2022)

Eye health in Papua New Guinea
por: Garap, Jambi, et al.
Publicado: (2021)

Genomic Sequencing of Dengue Virus Strains Associated with Papua New Guinean Outbreaks in 2016 Reveals Endemic Circulation of DENV-1 and DENV-2
por: Jonduo, Marinjho, et al.
Publicado: (2022)

Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati
por: Cama, Anaseini, et al.
Publicado: (2017)

The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma
por: Gwyn, Sarah, et al.
Publicado: (2021)

Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
por: Butcher, Robert, et al.
Publicado: (2020)

Mycoplasma genitalium macrolide and fluoroquinolone resistance in pregnant women in Papua New Guinea
por: Jonduo, Marinjho E, et al.
Publicado: (2023)

The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children
por: West, Sheila K., et al.
Publicado: (2020)

Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area
por: West, Sheila K., et al.
Publicado: (2018)

Comparison of Platforms for Testing Antibody Responses against the Chlamydia trachomatis Antigen Pgp3
por: Gwyn, Sarah, et al.
Publicado: (2017)

Validation of immunoassays for the Chlamydia trachomatis antigen Pgp3 using a chimeric monoclonal antibody
por: Goodhew, Brook, et al.
Publicado: (2023)

Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection
por: Vasileva, Hristina, et al.
Publicado: (2018)

Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units
por: Burr, Sarah E., et al.
Publicado: (2019)

Latent class modeling to compare testing platforms for detection of antibodies against the Chlamydia trachomatis antigen Pgp3
por: Wiegand, Ryan E., et al.
Publicado: (2018)

Diarrhoeal disease surveillance in Papua New Guinea: findings and challenges
por: Abdad, Mohammad Yazid, et al.
Publicado: (2020)

Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji
por: Macleod, Colin K., et al.
Publicado: (2016)

Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania
por: Chen, Xinyi, et al.
Publicado: (2022)

CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs
por: Goodhew, E. Brook, et al.
Publicado: (2012)

183. chlamydia Trachomatis Seroprevalence with a pgp3 Serologic Assay and Association with Pelvic Inflammatory Disease Among Women, United States, 2013–2016
por: Anyalechi, Gloria E, et al.
Publicado: (2020)

The World Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and Added Benefit of Testing for Antibodies to Chlamydia trachomatis pgp3 Protein: NESTS Study
por: Zambrano, Andrea I., et al.
Publicado: (2016)

Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis
por: Butcher, Robert, et al.
Publicado: (2018)

C. trachomatis pgp3 Antibody Prevalence in Young Women in England, 1993–2010
por: Horner, Paddy, et al.
Publicado: (2013)

Clonal Origins of Vibrio cholerae O1 El Tor Strains, Papua New Guinea, 2009–2011
por: Horwood, Paul F., et al.
Publicado: (2011)

A systematic review of historical and contemporary evidence of trachoma endemicity in the Pacific Islands
por: Handley, Becca L., et al.
Publicado: (2018)

Reduced-cost Chlamydia trachomatis-specific multiplex real-time PCR diagnostic assay evaluated for ocular swabs and use by trachoma research programmes
por: Butcher, Robert, et al.
Publicado: (2017)

Spatio-temporal epidemiology of the cholera outbreak in Papua New Guinea, 2009–2011
por: Horwood, Paul F, et al.
Publicado: (2014)

Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands
por: Butcher, Robert M. R., et al.
Publicado: (2016)

An observational study of the reactogenicity and immunogenicity of 13-valent pneumococcal conjugate vaccine in women of childbearing age in Papua New Guinea
por: Javati, Sarah, et al.
Publicado: (2020)

Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
por: Potroz, Michael G., et al.
Publicado: (2015)

Correction: Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands
por: Butcher, Robert M. R., et al.
Publicado: (2016)

Prevalence of Chlamydia trachomatis-Specific Antibodies before and after Mass Drug Administration for Trachoma in Community-Wide Surveys of Four Communities in Nepal
por: Gwyn, Sarah E., et al.
Publicado: (2018)

Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study
por: Last, Anna, et al.
Publicado: (2017)

Divergent Barmah Forest Virus from Papua New Guinea
por: Caly, Leon, et al.
Publicado: (2019)

Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009)

Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive Chlamydia trachomatis Biovars
por: Patton, Michael John, et al.
Publicado: (2018)

Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis
por: Hu, Victor H., et al.
Publicado: (2013)

Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
por: Last, Anna R., et al.
Publicado: (2014)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands
por: Marks, M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4vt41hndaj5td2117qa0edaom4